Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,296 papers from all fields of science
Search
Sign In
Create Free Account
Stage 0 Bladder Urothelial Carcinoma
Known as:
Stage 0 Bladder Urothelial Carcinoma AJCC v7
, Stage 0 Transitional Cell Carcinoma of Urinary Bladder
, Non-Invasive Bladder Urothelial Carcinoma
Expand
Stage 0 includes: 0a (Ta, N0, M0); 0is (Tis, N0, M0). Ta: Noninvasive papillary carcinoma. Tis: Carcinoma in situ: "flat tumor". N0: No regional…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
19 relations
Epithelial Cells
Epithelium
Hematuria
Malignant Epithelial Cell
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
[The role of contrast-enhanced pulse inversion harmonic imaging (CEUS) and contrast-enhanced computed tomography (CECT) in the preoperative diagnosis of renal lesions].
P. Klézl
,
M. Kaspar
,
+7 authors
F. Záťura
Der Urologe (Ausg. A)
2018
Corpus ID: 195665895
OBJECTIVE The preoperative assessment of structural and functional changes in renal tumors using contrast-enhanced pulse…
Expand
2013
2013
Utility of ProEx C in the histologic evaluation of the neoplastic and nonneoplastic urothelial lesions.
N. Moatamed
,
Maria E. Vergara-Lluri
,
David Y. Lu
,
S. Apple
,
Susan Kerkoutian
,
J. Rao
Human Pathology
2013
Corpus ID: 20432978
2009
2009
Inverted urothelial papilloma of the urinary bladder with focal papillary pattern: a previously undescribed feature.
J. Albores–Saavedra
,
F. Chablé-Montero
,
O. Hernández-Rodrı́guez
,
D. Montante-Montes de Oca
,
A. Ángeles-Ángeles
Annals of Diagnostic Pathology
2009
Corpus ID: 21228113
2009
2009
Phase II study of aflibercept (VEGF-Trap) in patients (pts) with recurrent or metastatic transitional cell carcinoma (TCC) of the urothelium: A California Cancer Consortium trial.
P. Twardowski
,
W. Stadler
,
+6 authors
D. Gandara
Journal of Clinical Oncology
2009
Corpus ID: 26141293
e16030 Background: The role and efficacy of subsequent systemic therapies for advanced TCC following failure of frontline…
Expand
2007
2007
Significance of Denuded Urothelium in Papillary Urothelial Lesions
Christopher L. Owens
,
J. Epstein
American Journal of Surgical Pathology
2007
Corpus ID: 9463182
Flat urothelial carcinoma in situ (CIS) is often characterized by prominent dyscohesion with some cases having only a few…
Expand
Review
2004
Review
2004
Atypia in inverted urothelial papillomas: pathology and prognostic significance.
J. Broussard
,
P. Tan
,
J. Epstein
Human Pathology
2004
Corpus ID: 23488177
Review
2004
Review
2004
Eye metastasis form urothelial tumours
G. Nabi
,
S. Dadeya
,
P. Dogra
,
H. Lal
International Urology and Nephrology
2004
Corpus ID: 8950820
Obit is an infrequent site of metastasis from urothelial tumours. To the best of our knowledge there are less than ten case…
Expand
2002
2002
Urothelial ingrowth over demucosalized gastrocystoplasty: an experimental study
S. Abdel Hay
,
S. Soliman
,
M. E. Debeky
BJU International
2002
Corpus ID: 23976447
Objective To evaluate histopathologically the ingrowth of urothelium over a demucosalized gastric flap used for augmentation, as…
Expand
2001
2001
[Evaluation of usefulness of urinary nuclear matrix protein 22 (NMP22) in the detection of urothelial transitional cell carcinoma].
Y. Miyoshi
,
J. Matsuzaki
,
T. Miura
Hinyokika kiyo. Acta urologica Japonica
2001
Corpus ID: 11897901
We evaluated the usefulness of urinary nuclear matrix protein 22 (NMP22) compared to urinary cytology in the detection of…
Expand
1986
1986
How Accurate is Urine Cytology?
M. Curling
,
G. Broome
,
W. Hendry
Journal of the Royal Society of Medicine
1986
Corpus ID: 20108717
Exfoliative urinary cytology was performed on 260 new cases of histologically proven urothelial cancer. The site, size, shape and…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE